Visus Therapeutics
About:
Visus Therapeutics is a clinical-stage company developing innovative medicines.
Website: https://www.visustx.com/
Top Investors: RTW Investments, EQT Life Sciences, Johnson & Johnson Innovation – JJDC, Wille Finance
Description:
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
Total Funding Amount:
$56M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Seattle, Washington, United States
Founded Date:
2019-01-01
Founders:
Ben Bergo
Number of Employees:
11-50
Last Funding Date:
2021-08-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai